Shandong Jincheng Pharmaceutical and Chemical Co Ltd (300233) — Free Cash Flow Generation Index
Shandong Jincheng Pharmaceutical and Chemical Co Ltd (300233) has a Free Cash Flow Generation Index of 0.51x as of September 2025. Free cash flow of CN¥40.98 Million represents 1% of operating cash flow (CN¥79.81 Million). Read 300233 total debt and obligations for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Shandong Jincheng Pharmaceutical and Chemical Co Ltd Free Cash Flow Generation Index (2008–2025)
Historical FCF Generation Index trend for Shandong Jincheng Pharmaceutical and Chemical Co Ltd across 18 annual periods. Explore Shandong Jincheng Pharmaceutical and Che (300233) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Shandong Jincheng Pharmaceutical and Chemical Co Ltd (2008–2025)
Year-by-year Free Cash Flow Generation Index for Shandong Jincheng Pharmaceutical and Chemical Co Ltd. For the full company profile including market capitalisation, see Shandong Jincheng Pharmaceutical and Che (300233) market capitalisation.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.68x | CN¥218.76 Million | CN¥319.64 Million | CN¥100.88 Million | ▲ +31.8% |
| 2024 | 0.52x | CN¥153.97 Million | CN¥296.59 Million | CN¥142.61 Million | ▲ +7.3% |
| 2023 | 0.48x | CN¥321.18 Million | CN¥664.08 Million | CN¥342.90 Million | ▲ +204.7% |
| 2022 | -0.46x | CN¥-118.04 Million | CN¥255.63 Million | CN¥373.67 Million | ▼ -430.7% |
| 2021 | 0.14x | CN¥61.04 Million | CN¥437.19 Million | CN¥376.14 Million | ▼ -72.1% |
| 2020 | 0.50x | CN¥273.69 Million | CN¥546.13 Million | CN¥272.44 Million | ▲ +33.9% |
| 2019 | 0.37x | CN¥216.33 Million | CN¥577.98 Million | CN¥361.65 Million | ▲ +5591.8% |
| 2018 | 0.01x | CN¥2.32 Million | CN¥352.20 Million | CN¥349.88 Million | ▲ +102.4% |
| 2017 | -0.28x | CN¥-41.97 Million | CN¥151.83 Million | CN¥193.80 Million | ▼ -180.8% |
| 2016 | 0.34x | CN¥82.59 Million | CN¥241.48 Million | CN¥158.89 Million | ▲ +47.9% |
| 2015 | 0.23x | CN¥48.07 Million | CN¥207.92 Million | CN¥159.85 Million | ▼ -15.3% |
| 2014 | 0.27x | CN¥59.89 Million | CN¥219.46 Million | CN¥159.57 Million | ▲ +138.7% |
| 2013 | -0.71x | CN¥-66.26 Million | CN¥93.92 Million | CN¥160.18 Million | ▼ -170.3% |
| 2012 | -0.26x | CN¥-22.60 Million | CN¥86.61 Million | CN¥109.21 Million | ▲ +77.4% |
| 2011 | -1.15x | CN¥-72.31 Million | CN¥62.69 Million | CN¥135.00 Million | ▼ -380.1% |
| 2010 | -0.24x | CN¥-26.11 Million | CN¥108.67 Million | CN¥134.78 Million | ▼ -294.5% |
| 2009 | 0.12x | CN¥13.04 Million | CN¥105.62 Million | CN¥92.58 Million | ▲ +116.5% |
| 2008 | -0.75x | CN¥-22.64 Million | CN¥30.23 Million | CN¥52.87 Million | — |